Found 19 matching trials
A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
PHASE2The purpose of this study is to evaluate the efficacy of Bermekimab, compar...
Location
Dawes Fretzin Clinical Research Group
Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.
PHASE2The purpose of this study is to determine if CV-18C3 will reduce the rate o...
Location
Sutter Heart & Vascular Institute
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
PHASE2The purpose of this study is to evaluate the efficacy and safety of bermeki...
Location
California Allergy & Asthma Medical Group Inc.
Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris
PHASE2This is a 91-day phase II, open label trial of the true human monoclonal an...
Location
Moy, Fincher, and Chipps Facial Plastics and Dermatology
Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis
PHASE2This is a 73-day phase II, open label trial of the true human monoclonal an...
Location
West Kentucky Dermatology
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
PHASE2A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With ...
Location
Beach Clinical Research Inc
A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
PHASE2The purpose of this study is to evaluate the clinical efficacy of bermekima...
Location
Medical Dermatology Specialists
A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous Doses
PHASE1The purpose of the study is to assess the safety and tolerability of JNJ-77...
Location
Nucleus Network, Q-Pharm Pty Ltd
A Study of Bermekimab in Patients With Hidradenitis Suppurativa
PHASE2Phase 2 study of bermekimab in patients with moderate to severe Hidradeniti...
Location
Tennessee Clinical Research Center
Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
PHASE1The purpose of this study is to examine the safety and tolerability of CA-1...
Location
MD Anderson Cancer Center